Danske Bank’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.5M Buy
85,200
+6,000
+8% +$1.19M 0.03% 346
2026
Q2
$14.8M Buy
79,200
+34,300
+76% +$5.01M 0.03% 377
2026
Q1
$4.37M Buy
44,900
+41,800
+1,348% +$4.22M 0.01% 536
2025
Q4
$247K Buy
3,100
+1,000
+48% +$65.6K ﹤0.01% 657
2025
Q3
$98.1K Hold
2,100
– – ﹤0.01% 867
2025
Q2
$77.3K Buy
2,100
+1,900
+950% +$73K ﹤0.01% 916
2025
Q1
$7.07K Hold
200
– – ﹤0.01% 1133
2024
Q4
$8.75K Sell
200
-500
-71% -$25.2K ﹤0.01% 1125
2024
Q3
$31.7K Buy
+700
New +$30.5K ﹤0.01% 1272

Other funds holding RVMD

Danske Bank's RVMD Position: Q3 2026 in Review

Danske Bank increased its Revolution Medicines (RVMD) stake by 7.6% in Q3 2026, buying an estimated $1.19M and bringing the position to 85,200 shares worth $17.5M. The position accounts for 0.03% of the portfolio, ranked #346.

Danske Bank first reported a position in RVMD in Q3 2024 and has held it in 9 quarters since. 754 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Danske Bank held 85,200 shares of Revolution Medicines worth $17.5M as of Q3 2026.
  • Danske Bank bought 6,000 Revolution Medicines shares in Q3 2026, an estimated $1.19M.
  • Revolution Medicines made up 0.03% of Danske Bank's portfolio in Q3 2026, its #346 holding.
  • Danske Bank first reported a position in Revolution Medicines in Q3 2024 and has held it in 9 quarters since.
  • 754 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.